702 related articles for article (PubMed ID: 18343277)
1. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease.
Reilly MC; Gerlier L; Brabant Y; Brown M
Clin Ther; 2008 Feb; 30(2):393-404. PubMed ID: 18343277
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn's disease in the PRECiSE 2 study.
Feagan BG; Reilly MC; Gerlier L; Brabant Y; Brown M; Schreiber S
Aliment Pharmacol Ther; 2010 Jun; 31(12):1276-85. PubMed ID: 20298497
[TBL] [Abstract][Full Text] [Related]
3. Clinically meaningful improvement in health-related quality of life in a randomized controlled trial of certolizumab pegol maintenance therapy for Crohn's disease.
Feagan BG; Coteur G; Tan S; Keininger DL; Schreiber S
Am J Gastroenterol; 2009 Aug; 104(8):1976-83. PubMed ID: 19471252
[TBL] [Abstract][Full Text] [Related]
4. Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis.
Maksymowych WP; Gooch KL; Wong RL; Kupper H; van der Heijde D
J Rheumatol; 2010 Feb; 37(2):385-92. PubMed ID: 19955052
[TBL] [Abstract][Full Text] [Related]
5. A new validation of the Spanish Work Productivity and Activity Impairment Questionnaire-Crohn's disease version.
Vergara M; Montserrat A; Casellas F; Villoria A; Suarez D; Maudsley M; Gallardo O; Ricart E; Calvet X
Value Health; 2011; 14(6):859-61. PubMed ID: 21914506
[TBL] [Abstract][Full Text] [Related]
6. Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn's disease with prior loss of response to infliximab.
Feagan BG; Sandborn WJ; Wolf DC; Coteur G; Purcaru O; Brabant Y; Rutgeerts PJ
Aliment Pharmacol Ther; 2011 Mar; 33(5):541-50. PubMed ID: 21223344
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.
Feagan BG; Hanauer SB; Coteur G; Schreiber S
Aliment Pharmacol Ther; 2011 May; 33(10):1143-51. PubMed ID: 21443536
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease version.
Vergara M; Montserrat A; Casellas F; Maudsley M; Gallardo O; Ricart E; Calvet X
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):809-15. PubMed ID: 19404204
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's disease.
Coteur G; Feagan B; Keininger DL; Kosinski M
Aliment Pharmacol Ther; 2009 May; 29(9):1032-41. PubMed ID: 19222413
[TBL] [Abstract][Full Text] [Related]
10. Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis.
Reilly MC; Gooch KL; Wong RL; Kupper H; van der Heijde D
Rheumatology (Oxford); 2010 Apr; 49(4):812-9. PubMed ID: 20100797
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
Colombel JF; Sandborn WJ; Rutgeerts P; Kamm MA; Yu AP; Wu EQ; Pollack PF; Lomax KG; Chao J; Mulani PM
Am J Gastroenterol; 2009 May; 104(5):1170-9. PubMed ID: 19352339
[TBL] [Abstract][Full Text] [Related]
12. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis.
Kimball AB; Yu AP; Signorovitch J; Xie J; Tsaneva M; Gupta SR; Bao Y; Mulani PM
J Am Acad Dermatol; 2012 Feb; 66(2):e67-76. PubMed ID: 21616560
[TBL] [Abstract][Full Text] [Related]
13. The validity and accuracy of the Work Productivity and Activity Impairment questionnaire--irritable bowel syndrome version (WPAI:IBS).
Reilly MC; Bracco A; Ricci JF; Santoro J; Stevens T
Aliment Pharmacol Ther; 2004 Aug; 20(4):459-67. PubMed ID: 15298641
[TBL] [Abstract][Full Text] [Related]
14. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
Loftus EV; Feagan BG; Colombel JF; Rubin DT; Wu EQ; Yu AP; Pollack PF; Chao J; Mulani P
Am J Gastroenterol; 2008 Dec; 103(12):3132-41. PubMed ID: 18853973
[TBL] [Abstract][Full Text] [Related]
15. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
Hone D; Cheng A; Watson C; Huang B; Bitman B; Huang XY; Gandra SR
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1564-72. PubMed ID: 23554320
[TBL] [Abstract][Full Text] [Related]
16. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
Irvine EJ; Zhou Q; Thompson AK
Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
[TBL] [Abstract][Full Text] [Related]
17. Certolizumab pegol for the management of Crohn's disease in adults.
Rivkin A
Clin Ther; 2009 Jun; 31(6):1158-76. PubMed ID: 19695385
[TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy with certolizumab pegol for Crohn's disease.
Schreiber S; Khaliq-Kareemi M; Lawrance IC; Thomsen OØ; Hanauer SB; McColm J; Bloomfield R; Sandborn WJ;
N Engl J Med; 2007 Jul; 357(3):239-50. PubMed ID: 17634459
[TBL] [Abstract][Full Text] [Related]
19. Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis: a cross-sectional UK study.
Espahbodi S; Bassett P; Cavill C; Freeth M; Hole J; Sengupta R
Clin Exp Rheumatol; 2017; 35(4):571-578. PubMed ID: 28240589
[TBL] [Abstract][Full Text] [Related]
20. Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease.
Augustine JM; Lee JK; Armstrong EP
Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):599-609. PubMed ID: 25209304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
